Alicia Minor

Title: Alicia Minor - Innovator in Proangiogenic Protein Cocktails

Introduction

Alicia Minor is a prominent inventor based in Providence, RI (US). She has made significant contributions to the field of biomedical engineering, particularly in the development of innovative solutions for ischemic tissue revascularization. Her work focuses on creating customizable systems that enhance vascularization, which is crucial for healing and recovery in various medical conditions.

Latest Patents

Alicia Minor holds a patent for her invention titled "Proangiogenic protein cocktails delivered in custom biomaterials to revascularize ischemic tissue." This invention provides a highly versatile system designed to promote vascularization in ischemic tissue. The system consists of a fully defined, customizable hydrogel that is loaded with a potent cocktail of proangiogenic growth factors. The hydrogel's mechanical, degradation, and factor release behavior can be tailored to meet the specifications of any given target tissue or ischemic disease state. The growth factor cocktail can be optimized for maximal vessel density or size to fulfill the perfusion requirements of the tissue. The embodiments of the disclosure concern methods and compositions of the system, with examples of preparation for both injectable and implantable delivery modes.

Career Highlights

Alicia Minor's career is marked by her dedication to advancing medical technology through innovative research. She has successfully developed a system that addresses critical challenges in tissue engineering and regenerative medicine. Her work has the potential to significantly improve patient outcomes in various ischemic conditions.

Collaborations

Alicia collaborates with esteemed colleagues, including Stephanie Roser and Kareen L K Coulombe, who contribute to her research efforts at Brown University. Their combined expertise enhances the development and application of her innovative solutions.

Conclusion

Alicia Minor is a trailblazer in the field of biomedical engineering, with her patent for proangiogenic protein cocktails representing a significant advancement in the treatment of ischemic tissue. Her work exemplifies the impact of innovation in healthcare, paving the way for future developments in regenerative medicine.